Thallous Chloride Tl 201 Injection, Solution
Product Images NDC 69945-120

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Thallous Chloride Tl 201 (NDC 69945-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Curium Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Thallous Chloride Tl 201 69945 1)

A line graph depicting the percentage of total radioactivity of thallium isotopes Tl 200 and Tl 202 over time from calibration date to expiration date in days. The x-axis represents days relative to calibration and expiration dates, while the y-axis shows percentage values on a logarithmic scale.*

FDA Label Image

Display Panel A120co (Thallous Chloride Tl 201 69945 2)

Label for Thallous Chloride Tl 201 Injection, a sterile, non-pyrogenic diagnostic solution for intravenous use. The label states each milliliter contains 37 MBq (1 mCi) thallous chloride Tl 201 with added sodium chloride and benzyl alcohol as a preservative. Manufactured by Curium US LLC, Maryland Heights, MO. The label includes radioactive material caution and storage instructions at controlled room temperature (20° to 25°C).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.